Compounds > sorafenib
Page last updated: 2024-09-05

sorafenib and Papulosquamous Disorders

sorafenib has been researched along with Papulosquamous Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouffard, D; Joncas, V; Krasny, M; Provost, N; Sammour, R1
Sahai, S; Swick, BL1
De Onzoño, LI; García-Arpa, M; Martinez-Martínez, ML; Rodríguez-Vázquez, M1

Other Studies

3 other study(ies) available for sorafenib and Papulosquamous Disorders

ArticleYear
A distinct cutaneous reaction to sorafenib and a multikinase inhibitor.
    International journal of dermatology, 2008, Volume: 47, Issue:7

    Topics: Administration, Oral; Benzenesulfonates; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; Head; Humans; Immunohistochemistry; Kidney Neoplasms; Male; Middle Aged; Neck; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Risk Assessment; Severity of Illness Index; Skin Diseases, Papulosquamous; Sorafenib; Treatment Outcome

2008
Hyperkeratotic eruption, hand-foot skin reaction, facial erythema, and stomatitis secondary to multi-targeted kinase inhibitor sorafenib.
    International journal of dermatology, 2010, Volume: 49, Issue:10

    Topics: Benzenesulfonates; Carcinoma, Renal Cell; Erythema; Humans; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Skin Diseases, Papulosquamous; Sorafenib; Stomatitis

2010
Atypical linear toxicodermia by sorafenib.
    International journal of dermatology, 2010, Volume: 49, Issue:10

    Topics: Adult; Benzenesulfonates; Biopsy; Edema; Female; Hepatolenticular Degeneration; Humans; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Skin; Skin Diseases, Papulosquamous; Sorafenib

2010